MAPT and Alzheimer disease: Since tau aggregates in AD are paired helical filaments (PHF) composed of mixed 3R/4R tau aggregates [14], they therefore supported the notion that 18F-AV-1451 has the specific binding capacity for AD-like tau pathology [10].